Stifel Financial’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $843K | Sell |
75,059
-70,318
| -48% | -$790K | ﹤0.01% | 2450 |
|
|
2025
Q1 | $664K | Buy |
145,377
+4,235
| +3% | +$19.4K | ﹤0.01% | 2498 |
|
|
2024
Q4 | $796K | Buy |
141,142
+9,736
| +7% | +$54.9K | ﹤0.01% | 2399 |
|
|
2024
Q3 | $636K | Buy |
131,406
+16,842
| +15% | +$81.5K | ﹤0.01% | 2522 |
|
|
2024
Q2 | $559K | Buy |
114,564
+609
| +0.5% | +$2.97K | ﹤0.01% | 2554 |
|
|
2024
Q1 | $1.51M | Buy |
113,955
+29,246
| +35% | +$388K | ﹤0.01% | 1925 |
|
|
2023
Q4 | $1.18M | Buy |
84,709
+57,052
| +206% | +$795K | ﹤0.01% | 2034 |
|
|
2023
Q3 | $367K | Buy |
27,657
+13,898
| +101% | +$184K | ﹤0.01% | 2670 |
|
|
2023
Q2 | $258K | Buy |
+13,759
| New | +$258K | ﹤0.01% | 2920 |
|